z-logo
open-access-imgOpen Access
C 3 dysregulation due to factor H deficiency is mannan‐binding lectin‐associated serine proteases ( MASP )‐1 and MASP ‐3 independent in vivo
Author(s) -
Ruseva M. M.,
Takahashi M.,
Fujita T.,
Pickering M. C.
Publication year - 2014
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12244
Subject(s) - alternative complement pathway , mannan binding lectin , lectin pathway , complement system , factor h , complement factor b , proteases , immunology , complement component 2 , biology , chemistry , lectin , biochemistry , immune system , enzyme
Summary Uncontrolled activation of the complement alternative pathway is associated with complement‐mediated renal disease. Factor B and factor D are essential components of this pathway, while factor H ( FH ) is its major regulator. In complete FH deficiency, uncontrolled C 3 activation through the alternative pathway results in plasma C 3 depletion and complement‐mediated renal disease. These are dependent on factor B . Mannan‐binding lectin‐associated serine proteases 1 and 3 ( MASP ‐1, MASP ‐3) have been shown recently to contribute to alternative pathway activation by cleaving pro‐factor D to its active form, factor D . We studied the contribution of MASP ‐1 and MASP ‐3 to uncontrolled alternative pathway activation in experimental complete FH deficiency. Co‐deficiency of FH and MASP ‐1/ MASP ‐3 did not ameliorate either the plasma C 3 activation or glomerular C 3 accumulation in FH ‐deficient mice. Our data indicate that MASP ‐1 and MASP ‐3 are not essential for alternative pathway activation in complete FH deficiency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom